---
schema_version: "secwatch.filing_event.v1"
accession: "0000097745-22-000044"
form_type: "8-K"
ticker: "TMO"
cik: "0000097745"
company_name: "THERMO FISHER SCIENTIFIC INC."
filed_at: "2022-07-28T23:59:59+00:00"
generated_at: "2026-06-24T07:56:07.409169+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Thermo Fisher Q2 revenue $10.97B (+18% YoY); GAAP EPS $4.22, adjusted EPS $5.51

## Summary
- Revenue $10.97B (+18% YoY); core organic growth 13%; COVID testing revenue $0.63B.
- GAAP diluted EPS $4.22 vs $4.61 YoY; adjusted EPS $5.51 vs $5.60 YoY.
- Adjusted operating margin 23.7% vs 29.0% YoY; GAAP operating income $2.00B.
- Launched new products including Gibco CTS TrueCut Cas9 and Phadia 2500+ series.
- Company to provide updated 2022 financial guidance during earnings call.

## SEC filing metadata
- accession: 0000097745-22-000044
- form_type: 8-K
- ticker: TMO
- cik: 0000097745
- company_name: THERMO FISHER SCIENTIFIC INC.
- filed_at: 2022-07-28T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/97745/000009774522000044/0000097745-22-000044-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/97745/000009774522000044/tmo-20220728.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000097745-22-000044
- JSON: https://secwatch.observer/filing/0000097745-22-000044.json
- Plain text: https://secwatch.observer/filing/0000097745-22-000044.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.